As recent experience, including unique data from the SARS-CoV-2 pandemic, has shown, treatment of patients with community-acquired pneumonia is focused on those with severe disease. The rapid development of inflammation in lung tissue clearly demonstrates the futility of etiotropic medications, which lack the properties of effective first aid in such conditions. The lack of correlation between pneumonia severity and the type of pathogen, as well as the persistence of underlying disease mechanisms regardless of the etiology, necessitate the earliest possible application of pathogenetic treatment to ensure positive results and prevent complications.
Keywords:
Published on: Mar 3, 2026 Pages: 1-6
Full Text PDF
Full Text HTML
DOI: 10.17352/aprc.000094
CrossMark
Publons
Harvard Library HOLLIS
Search IT
Semantic Scholar
Get Citation
Base Search
Scilit
OAI-PMH
ResearchGate
Academic Microsoft
GrowKudos
Universite de Paris
UW Libraries
SJSU King Library
SJSU King Library
NUS Library
McGill
DET KGL BIBLiOTEK
JCU Discovery
Universidad De Lima
WorldCat
VU on WorldCat

PTZ: We're glad you're here. Please click "create a new query" if you are a new visitor to our website and need further information from us.
If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click "take me to my Query."